Merck, a leading science and technology company, today announced that its Life Science business sector has launched a first-of-its-kind solution that prepares and instantly dispenses culture media for use in microbiological food testing. The innovative ReadyStream® system highlights Merck’s commitment to customers by enhancing testing efficiency through innovation.
Darmstadt, Germany, April 21, 2022 – Merck, a leading science and technology company, today announced that its Life Science business sector has launched a first-of-its-kind solution that prepares and instantly dispenses culture media for use in microbiological food testing. The innovative ReadyStream® system highlights Merck’s commitment to customers by enhancing testing efficiency through innovation.
“Culture media and sample preparation is typically a time-consuming, multi-step process for food testing labs, especially for those testing in large sample volumes,” said Ian Jennings, Head of BioMonitoring, Life Science business sector, Merck. “We are transforming the way QC Labs test by allowing the instrument to do most of the work, saving lab technicians time, resources and lab space.”
With traditional microbiological food testing methods, quality control lab technicians prepare the culture media themselves or use voluminous bags of ready-to-use media. The ReadyStream® system carries several significant advantages over traditional methods including:
Learn more about Merck’s new ReadyStream® system.
Register for the ReadyStream® webinar on April 27, 2022.
About Merck
Merck, a leading science and technology company, operates across life science, healthcare and electronics. More than 64,000 employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live. From providing products and services that accelerate drug development and manufacturing as well as discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere. In 2022, Merck generated sales of € 22.2 billion in 66 countries.
Scientific exploration and responsible entrepreneurship have been key to Merck’s technological and scientific advances. This is how Merck has thrived since its founding in 1668. The founding family remains the majority owner of the publicly listed company. Merck holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the business sectors of Merck operate as MilliporeSigma in life science, EMD Serono in healthcare, and EMD Electronics in electronics.
All Merck news releases are distributed by email at the same time they become available on the Merck website. Please go to www.merckgroup.com/subscribe to register online, change your selection or discontinue this service.
Timo Breiner
Email: timo.breiner@merckgroup.com
Phone: +49 6151 72-55707
Latest Press Releases
To continue reading please sign in or create an account.
Don't Have An Account?